William Stohl, MD, PhD

Professor of Medicine

Chief, Division of Rheumatology

Image of William Stohl, MD, PhD
Is this your profile? Click to edit

Overview

Dr. Stohl’s research focus is on systemic lupus erythematosus (pathogenesis, natural course of disease, treatment, animal models, immunologic disturbances, novel therapeutics); rheumatoid arthritis (pathogenesis, natural course of disease, treatment, animal models, immunologic disturbances, novel therapeutics); Sjogren’s syndrome (biomarkers, novel therapeutics); and B cells (basic biology, role in autoimmune diseases, development of targeted therapies).

Dr. Stohl received his M.D. (1977) and his Ph.D. (1979) from the University Pennsylvania.

Awards

  • University of Pennsylvania School of Medicine: Upjohn Award, 1979
  • Arthritis Foundation Southern California Chapter: James R. Klinenberg, M.D. Award, 2003

Research Funding

  • The vital role of BAFF in the development of SLE
    NIH · R01AR050193 · May 16, 2006 – Aug 31, 2012 · Role: Principal Investigator
  • T CELL CYTOLYTIC ACTIVITY IN SLE
    NIH · R01AR041006 · Aug 12, 1993 – Jun 30, 2002 · Role: Principal Investigator
  • POLYMORPHISM WITHIN T4/LEU3 AND SLE
    NIH · R23AR036527 · Jan 1, 1986 – Jun 30, 1989 · Role: Principal Investigator

Publications

  • Late-Onset Rheumatoid Arthritis and Air Pollution in a Multiethnic Cohort. Arthritis Rheumatol. 2026 Jul; 78(7):1425-1436.. View in PubMed
  • New biological agents in systemic lupus erythematosus. Expert Opin Biol Ther. 2026 Jan-Feb; 26(2):133-147.. View in PubMed
  • Considering Pregnancy: Duality in the Reproductive Journey and Decision-Making in Hispanic Women With Systemic Lupus Erythematosus in the United States. ACR Open Rheumatol. 2026 Feb; 8(2):e70182.. View in PubMed
  • Rheumatic Immune-Related Adverse Events: Immune Checkpoint Inhibitor Therapy and Ramifications for Health Disparities. Cureus. 2025 Aug; 17(8):e90585.. View in PubMed
  • Sex-Associated Disparities in Industry Payments to US Authors in High-Impact Rheumatology Journals: Correlation with Author Impact. ACR Open Rheumatol. 2025 Aug; 7(8):e70078.. View in PubMed
  • Discriminating Disease Flare From Infection in Febrile Patients With Systemic Lupus Erythematosus in a Safety-Net Hospital System: A Multicenter Study. ACR Open Rheumatol. 2025 Jun; 7(6):e70051.. View in PubMed
  • BAFF promotes follicular helper T cell development and germinal center formation through BR3 signal. JCI Insight. 2024 11 08; 9(21).. View in PubMed
  • Contributions of each of the BAFF receptors to the lymphocyte profiles in C57BL/6 mice. Immunology. 2024 12; 173(4):689-711.. View in PubMed
  • T cell Dissimilarities in B Cell Activating Factor-Deficient Versus B Cell Activating Factor Receptor 3-Deficient Systemic Lupus Erythematosus-Prone NZM 2328 Mice as Contributors to Their Divergent Clinical Outcomes. ACR Open Rheumatol. 2024 Nov; 6(11):756-768.. View in PubMed
  • Innate and adaptive immune cell interaction drives inflammasome activation and hepatocyte apoptosis in murine liver injury from immune checkpoint inhibitors. Cell Death Dis. 2024 02 14; 15(2):140.. View in PubMed